EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pharmacogenomics in Orofacial Clefts Care: Insights from Whole-Genome Sequencing of Case-Parents Trios

Elvis Poku-Adusei, Gideon Okyere Mensah, Christian Opoku Asamoah iD, Bruce Tsri, Hafsa Akeeya, Abass Shaibu Danbaki, Solomon Obiri-Yeboah, Tamara D Busch iD, Lawrence Sheringham Borquaye, Peter Donkor, Azeez Butali iD, Lord Jephthah Joojo Gowans iD

Journal of Personalized Medicine · 30.09.2025 · 15 (10) · 456

DOI: 10.3390/jpm15100456 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Personalized Medicine, online erschienen am 30.09.2025. Verfasst von Elvis Poku-Adusei und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biotechnology, College of Science, KNUST, Kumasi 00233, Ghana. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCR NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Orofacial clefts (OFCs) are among the most common birth defects globally, sometimes exacerbated by adverse drug reactions (ADRs) from corticosteroids and antiepileptics. Comprehending the pharmacogenomic and pharmacogenetic elements that lead to ADRs is essential for enhancing precision medicine and clinical outcomes. This study examines rare genetic variants in drug-metabolizing and drug-transporting genes among Ghanaian and Nigerian families with a history of OFCs, intending to assess their pathogenicity and functional implications.

Methods

We recruited 104 Ghanaian families and 26 Nigerian families, generating whole-genome sequencing (WGS) data from 390 individuals (130 case-parent trios). DNA isolated from saliva and buccal swab samples underwent WGS, and subsequent WGS data were analyzed through extensive bioinformatics analyses. Variants were called and annotated using the GATK workflow. The HOPE in silico modeling tool evaluated the structural impact of genetic variants on encoded proteins, while molecular docking using PyRx examined alterations in ligand binding affinity.

Results

Our study revealed pathogenic variants in vital genes associated with drug metabolism and transport, specifically CYP1A2, CYP2C18, CYP27A1, CYP2B6, SLC6A2, and ABCC3. Structural modeling research demonstrated substantial size, charge, conformation, and hydrophobicity variations between wildtype and mutant proteins. Variants positioned near conserved regions or within functional domains were anticipated to be deleterious, potentially compromising protein function and ligand interactions. Molecular docking studies verified changes in binding affinities between wildtype and mutant proteins for common ligands. The identified variations were linked to the metabolism of frequently used pharmaceuticals in Africa, such as caffeine, ketoconazole, efavirenz, carbamazepine, and artemether.

Conclusions

These findings highlight the need for pharmacogenetic screening to inform personalized medicine, diminish ADRs, and enhance the clinical care of OFCs in Sub-Saharan Africa.

Schlagwörter

Stichwörter der Autor:innen

African populationsdrug metabolismmolecular dockingorofacial cleftspharmacogeneticspharmacogenomicsprotein structure

Autor:innen und Institutionen

  • Department of Biochemistry and Biotechnology, College of Science, KNUST, Kumasi 00233, Ghana.
  • Department of Oral and Maxillofacial Sciences, School of Dentistry, KNUST, Kumasi 00233, Ghana.
  • National Cleft Care Center, Komfo Anokye Teaching Hospital, Kumasi 00233, Ghana.
  • Department of Oral Pathology, Radiology and Medicine, The University of Iowa, Iowa City, IA 52242-1479, USA.
  • Department of Chemistry, College of Science, KNUST, Kumasi 00233, Ghana.
  • Department of Surgery, School of Medical Sciences, KNUST, Kumasi 00233, Ghana.

ORCID-Profile: Christian Opoku Asamoah, Tamara D Busch, Azeez Butali, Lord Jephthah Joojo Gowans

Förderung

  • NIDCR NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Poku-Adusei, E., Mensah, G. O., Asamoah, C. O., Tsri, B., Akeeya, H., Danbaki, A. S., Obiri-Yeboah, S., Busch, T. D., Borquaye, L. S., Donkor, P., Butali, A., & Gowans, L. J. J. (2025). Pharmacogenomics in Orofacial Clefts Care: Insights from Whole-Genome Sequencing of Case-Parents Trios. Journal of Personalized Medicine, 15(10), 456. https://doi.org/10.3390/jpm15100456

Vancouver

Poku-Adusei E, Mensah GO, Asamoah CO, Tsri B, Akeeya H, Danbaki AS, et al. Pharmacogenomics in Orofacial Clefts Care: Insights from Whole-Genome Sequencing of Case-Parents Trios. Journal of Personalized Medicine. 2025;15(10):456. doi:10.3390/jpm15100456

BibTeX
@article{PokuAdusei2025,
  author = {Poku-Adusei, Elvis and Mensah, Gideon Okyere and Asamoah, Christian Opoku and Tsri, Bruce and Akeeya, Hafsa and Danbaki, Abass Shaibu and Obiri-Yeboah, Solomon and Busch, Tamara D and Borquaye, Lawrence Sheringham and Donkor, Peter and Butali, Azeez and Gowans, Lord Jephthah Joojo},
  title = {Pharmacogenomics in Orofacial Clefts Care: Insights from Whole-Genome Sequencing of Case-Parents Trios},
  journal = {Journal of Personalized Medicine},
  year = {2025},
  volume = {15},
  number = {10},
  pages = {456},
  doi = {10.3390/jpm15100456}
}
Kostenlos starten →